[Pharmacological and clinical profile of rasburicase (Rasuritek)]. [electronic resource]
Producer: 20100817Description: 255-60 p. digitalISSN:- 0015-5691
- Adult
- Animals
- Antineoplastic Agents -- adverse effects
- Child
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Drug Design
- Female
- Gout Suppressants -- administration & dosage
- Humans
- Hyperuricemia -- etiology
- Infusions, Intravenous
- Male
- Tumor Lysis Syndrome -- etiology
- Urate Oxidase -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.